Momentive Specialty Chemicals to Build Formaldehyde Plants in Louisiana

Momentive Specialty Chemicals has announced plans to build two new world-scale formaldehyde plants with total capacity for more than 400,000 t/y at its Geismar and Luling, Louisiana, production sites.

The Geismar plant, with a direct pipeline delivery system to the adjacent manufacturing sites of BASF and Huntsman, is expected to go on stream in the fourth quarter of 2015. The Luling unit, due to start up in the first quarter of 2016, will supply agrochemicals giant Monsanto through a direct pipeline.

Momentive, which claims to be the world's largest producer of formaldehyde, said the expansion projects, which received tax incentives from Louisiana Economic Development (LED), will cost $66 million and support 68 jobs.

The new site being built up around the plants will be the company's 20th Forest Products site in North America. It follows a recently announced expansion in Curitiba, Brazil.

Targeted investments such as these, in partnership with customers, are a key part of the company's global growth strategy, said Dale Plante, executive vice President of Momentive Specialty Chemicals and president of the Forest Products division.

The additional capacity, which is complementary to Momentive's existing integrated network, will enable the company to meet expected growth in the Gulf Coast region for several significant and long-time customers, Plante said.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.